Abstract: An ingot growing apparatus, according to an embodiment of the present invention, comprises: a growth furnace in which a main crucible accommodating molten silicon for growing an ingot is disposed; a preliminary melting part which receives and melts a solid silicon material and a dopant, and has a preliminary crucible that supplies the molten silicon to the main crucible; a transfer part which transfers the solid silicon material and the dopant to the preliminary crucible; a silicon supply part which supplies the solid silicon material to the transfer part; and a dopant supply part which is disposed on an upper side of the transfer part and supplies the dopant to the transfer part according to a concentration of the dopant melted in the main crucible.

Abstract: An ingot growth apparatus according to an embodiment of the present invention comprises: a growth furnace having a main crucible which is disposed within the growth furnace and holds molten silicon therein in order to grow an ingot; a preliminary melting part having a preliminary crucible which is supplied with a solid silicon material, melts the solid silicon material, and supplies the molten silicon to the main crucible; a temperature detection sensor which is disposed above the preliminary melting part and detects the temperature of the solid silicon material or molten silicon held in the preliminary melting part; and a control part which controls supply of the molten silicon from the preliminary crucible to the main crucible on the basis of the temperature detected by the temperature detection sensor.

Abstract: Disclosed is a method for controlling the supply of solid silicon to a preliminary crucible of an ingot growth apparatus for maintaining a constant amount of molten silicon in the preliminary crucible by measuring the height of the molten silicon in the preliminary crucible.

Abstract: A method for coding image information includes generating prediction information by predicting information on a current coding unit, and determining whether the information on the current coding unit is the same as the prediction information. When the information on the current coding unit is the same as the prediction information, a flag indicating that the information on the current coding unit is the same as the prediction information is coded and transmitted. When the information on the current coding unit is not the same as the prediction information, a flag indicating that the information on the current coding unit is not the same as the prediction information and the information on the current coding unit are coded and transmitted.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present invention relates to an apparatus for manufacturing an electrode assembly including a separator feeding unit including a first roll on which one side of a separator strip is wound and a second roll on which the other side of the separator strip is wound, wherein the first and second rolls respectively unwind the separator strip so that the separator strip is fed toward a core portion of the separator strip disposed between the first and second rolls; a separator folding unit for winding the separator strip around the core portion to form a separator spiral folded in a spiral shape about the core portion; a first electrode lamination unit for laminating first electrode members on one surface of the separator spiral; and a second electrode lamination unit for laminating second electrode members on the other surface of the separator spiral.

Abstract: The present disclosure relates to a novel use of EI24, and provides a novel use of EI24 involved in the improvement of EGFR-TKI drug resistance by inhibiting IGF-1R signaling. According to the present disclosure, the presence or absence of resistance to anti-cancer drugs may be determined by detecting an expression level of EI24. In addition, resistance to anti-cancer drugs may be inhibited, delayed, or improved using EI24 or an activating agent thereof. Moreover, by regulating a pathway of EI24-mediated resistance to anti-cancer drugs, the efficacy of existing anti-cancer drugs may be enhanced, and resistance to anti-cancer drugs may be inhibited, delayed, or improved.

Abstract: Provided herein are a pharmaceutical composition for the prevention and treatment of cancer, including, as an active ingredient, E124 protein or a fragment thereof, or an expression vector including a nucleotide sequence encoding the E124 protein or the fragment thereof, and a method of screening a cancer therapeutic agent candidate.

Abstract: The present disclosure relates to a novel use of EI24, and provides a novel use of EI24 involved in the improvement of EGFR-TKI drug resistance by inhibiting IGF-1R signaling. According to the present disclosure, the presence or absence of resistance to anti-cancer drugs may be determined by detecting an expression level of EI24. In addition, resistance to anti-cancer drugs may be inhibited, delayed, or improved using EI24 or an activating agent thereof. Moreover, by regulating a pathway of EI24-mediated resistance to anti-cancer drugs, the efficacy of existing anti-cancer drugs may be enhanced, and resistance to anti-cancer drugs may be inhibited, delayed, or improved.

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.

Abstract: Disclosed herein is a method for producing a cyst-expressed transgenic animal using a PDK2 gene. The production method comprises preparing a PKD2 protein expression vector, inserting the expression vector into the nucleus of a fertilized egg to produce a PKD2 expression vector-containing fertilized egg, and transplanting the produced fertilized egg into the uterus of a surrogate mother. According to the invention disclosed herein, there is provided a method for producing transgenic animals, in which cysts are expressed only by the overexpression of the PKD2 gene. Also, transgenic mice are provided which can be effectively used in the investigation of cyst expression mechanisms and cyst control systems.

Abstract: The application discloses a role of p62 in aging-related disease, such as development of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver, various tumors, increased male mortality, intracellular inclusion named sequestosome, and redox regulation. In particular the application discloses a method of detecting the formation of inclusion bodies in neurodegenerative diseases. The invention further relates to a method of screening for therapeutic agents that disperse the inclusions. Further, transgenic mice containing a mutation in the p62 gene and having a functionally disrupted p62 gene locus are also disclosed.

Abstract: The application discloses a role of p62 in aging-related disease, such as development of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver, various tumors, increased male mortality, intracellular inclusion named sequestosome, and redox regulation. In particular the application discloses a method of detecting the formation of inclusion bodies in neurodegenerative diseases. The invention further relates to a method of screening for therapeutic agents that disperse the inclusions. Further, transgenic mice containing a mutation in the p62 gene and having a functionally disrupted p62 gene locus are also disclosed.

Abstract: Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a jab1 protein.

Abstract: The application discloses a role of p62 in aging-related disease, such as development of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver, various tumors, increased male mortality, intracellular inclusion named sequestosoine, and redox regulation. In particular the application discloses a method of detecting the formation of inclusion bodies in neurodegenerative diseases. The invention further relates to a method of screening for therapeutic agents that disperse the inclusions. Further, transgenic mice containing a mutation in the p62 gene and having a functionally disrupted p62 gene locus are also disclosed.